The program focused on the current knowledge in reproductive and endocrine toxicological pathology. A broad range of expertise and ideas were presented in the elds of horm onal carcinogenesis, thyroid, adrenal, pituitary and pancreatic endocrine pathology, and male and female reproductive toxicology. The traditional areas of endocrine and reproductive toxicological pathology were expanded to include mammary gland biology and cancer, light cycle/melatonin and nutrition. Endocrine disruption was addressed within the arenas of traditional reproductive toxicology as well as non-endocrine m ediated, indirect mechanisms. A major theme of the program was that the m orphology of endocrine and reproductive organs is best interpreted within the fram ework of understanding molecular and cellular hormone action and toxicant interaction.
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The keynote speaker, Dr. J. Carl Barrett, who spoke on the effects of horm ones and cancer, introduced this concept. Historically, horm ones were thought to in uence cancer by stimulation of cell proliferation. However, current paradigm s of horm ones and cancer suggest that hormones and horm one receptor agonists act by not one single mechanism but by many mechanisms to lead to cancer. Hormones can inhibit cell death in addition to stimulating cell proliferation; hormones effect cell invasion and metastasis; they may induce heritable changes in gene expression like DNA m ethylation, and hormones may induce m utagenic events.
How horm ones transmit their effects and how xenobiotics work as agonists or antagonists of horm one action were the topics of discussion of Drs. George Stancel, Tim Willson and William Greenlee. All emphasized that hormones act through receptor signal transduction pathways. The sim ple m odel for steroid hormone binding is that once bound, receptors translocate to the nucleus, physically contact DNA and effect gene transcription. W hat we now know is that these interactions are m uch more complex. For example, many receptors have m ultiple isoforms. The estrogen receptor (ER) has two forms currently recognized, ER and ER , each with different gene products, with different tissue distribution, and often sim ilar but not identical ligand binding properties. Additional complexities exist because gene activation or inhibition by a hormone depends on what groups of coactivator or repressor molecules bind to hormone-receptor com plexes. Dr. Willson reminded us that in addition to the many known nuclear receptors many others are thought to be the orphan receptors. Orphan receptors include receptors for xenobiotics and have broad binding af nity and may have evolved as xenobiotics sensors to protect the body from harmful chemicals in the environment. In the classic sense of endocrine disruptors, xenobiotics like TCDD (dioxin) bind to a receptor to mediate its effect. These effects may include altering cell proliferation, differentiation, and m ay lead to cancer in som e organs but inhibit cancer in other organs. And in this example lies the com plexity of hormone-receptor interactions.
For the pathologist, the questions of m olecular and cellular m echanisms arise from the tissue changes. To this effort, Dr. Charles Capen presented an outstanding comprehensive overview of structural and functional lesions in endocrine organs. Selected exam ples were used to illustrate primary and secondary organ hyperfunction or hypofunction and the resulting morphological changes associated with these states. The m orphological changes were underscored by detailed functional and mechanistic discussions of thyroid toxicity and adrenal gland. W hile the male and female reproductive systems were presented as separate venues, the sessions and speakers were com plimentary in their approaches to reproductive toxicological pathology. Morphologic overviews of the male and fem ale reproductive lesions were presented as the foundation for each perspective session. A comm on idea was that organ-speci c toxicity and cancers occur in gender-speci c patterns, yet m any of the underlying mechanisms of perturbations are sim ilar. Moreover, histopathological evaluation of the reproductive organs can be optimized in temporal studies that take into account the natural cycles of the animal. This was true for rodents as well as for nonhuman primates. Mammary gland biology, pathology and toxicology was included as a session to emphasize that these glands are horm one-dependent and pathologists should evaluate them with respect to the reproductive and endocrine status. To this extent Drs. Michael Gould, Pamela Blackshear and L. M ichelle Bennett discussed genetics, anim al models and m ethodologies, respectively. Detailed discussions were presented to highlight models of m amm ary gland biology and cancer including chem ically mediated models of mammary gland cancer in rats and mice as well as genetically altered models. Pathologists are called upon to look at m amm ary lesions but also assess m ammary gland development and branching. Evaluations of whole m ounts were presented as a useful tool to evaluate such endpoints.
The nal sessions of the meeting were dedicated to the effects of nutritional modulation on the endocrine and reproductive function and to tie in the concepts of hormone interaction, growth, and organ function. Details for assessing pancreatic function and morphology and the basis for diabetes were presented by Dr. Jan Wagner. Dietar y restriction is the most comm only used modulator of health and disease in animal models. Dr. Kevin Keenan presented a thoughtful and thorough discussion of how dietary restriction effects the pathology in rodent models. Dr. Steve Hursting presented new paradigm s for understanding the nutrition-gene interaction and chemoprevention studies using genetically engineered p-53 mutant mice. The session ended with Dr. Richard Miller discussing the effects of peroxisome proliferators on liver function. He highlighted the point that primary changes in liver function can cause secondary changes in the metabolism of thyroid hormone and thyroid function. This concept of non-endocrine mediated endocrine disruption ser ved as an important reminder to toxicological pathologists that the whole anim al response to an exposure, whether environmental stress, toxicant or chem otherapeutic agent, depends on a host of inter-related signals and functions. This meeting in part was to address these complexities in the endocrine and reproductive systems and provide the knowledge and tools for us to determine the signi cant pathologies.
